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RESEARCH ARTICLE
Identification of antigenic Sarcoptes scabiei
proteins for use in a diagnostic test and of
non-antigenic proteins that may be
immunomodulatory
Marjorie S. Morgan, S. Dean Rider, Jr., Larry G. Arlian*
Department of Biological Sciences, Wright State University, Dayton, OH, United States of America
* larry.arlian@wright.edu
Abstract
Background
Scabies, caused by the mite, Sarcoptes scabiei, infects millions of humans, and many wild
and domestic mammals. Scabies mites burrow in the lower stratum corneum of the epider-
mis of the skin and are the source of substances that are antigenic or modulate aspects of
the protective response of the host. Ordinary scabies is a difficult disease to diagnose.
Objective
The goal of this project was to identify S. scabiei proteins that may be candidate antigens
for use in a diagnostic test or may be used by the mite to modulate the host’s protective
response.
Methods
An aqueous extract of S. scabiei was separated by 2-dimensional electrophoresis and pro-
teins were identified by mass spectrometry. A parallel immunoblot was probed with serum
from patients with ordinary scabies to identify IgM and/or IgG-binding antigens. The genes
coding for 23 selected proteins were cloned into E. coli and the expressed recombinant pro-
teins were screened with serum from patients with confirmed ordinary scabies.
Results
We identified 50 different proteins produced by S. scabiei, 34 of which were not previously
identified, and determined that 66% were recognized by patient IgM and/or IgG. Fourteen
proteins were screened for use in a diagnostic test but none possessed enough sensitivity
and specificity to be useful. Six of the 9 proteins selected for the possibility that they may be
immunomodulatory were not recognized by antibodies in patient serum.
Conclusions
Thirty-three proteins that bound IgM and/or IgG from the serum of patients with ordinary sca-
bies were identified. None of the 14 tested were useful for inclusion in a diagnostic test. The
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identities of 16 proteins that are not recognized as antigens by infected patients were also
determined. These could be among the molecules that are responsible for this mite’s ability
to modulate its host’s innate and adaptive immune responses.
Author summary
Scabies, caused by the mite, Sarcoptes scabiei, infects millions of humans, and many wild
and domestic mammals. Scabies mites burrow in the lower stratum corneum of the epi-
dermis of the skin and are the source of substances that are antigenic or modulate aspects
of the protective response of the host. Ordinary scabies is a difficult disease to diagnose.
We identified 50 different proteins produced by S. scabiei, 33 of which bound IgM and/or
IgG from the serum of patients with ordinary scabies. A set of 23 recombinant proteins
were produced and screened for use in a diagnostic test but none possessed enough sensi-
tivity and specificity to warrant further consideration although some could be among the
molecules that are responsible for this mite’s ability to modulate its host’s innate and adap-
tive immune responses.
Introduction
Scabies is a worldwide disease that affects millions of humans, other species of primates, and
many wild and domestic mammals. It is caused by the itch mite, Sarcoptes scabiei, that burrows
in the lower stratum corneum of the epidermis of the skin. Scabies mites are the source of
substances that modulate certain aspects of the inflammatory innate and adaptive immune
response of the host allowing it to evade detection by the host until it is able to establish a thriv-
ing population [1–12]. Ordinary scabies is a difficult disease to diagnose and there are no diag-
nostic blood tests with adequate sensitivity and specificity available to identify patients early in
the course of an infection [13].
The goal of this project was to identify S. scabiei proteins that (1) may be candidate antigens
for use in a diagnostic test or (2) may be among those used by the mite to modulate the host’s
protective responses.
Materials and methods
Ethics statement
Serum from patients with confirmed ordinary scabies was collected under Human Subjects
Protocol (HSP) #0205 as approved by the Wright State University Institutional Review Board
(IRB). All patients were adults and all provided written informed consent. Negative control
sera were previously provided to us without personal identifiers under protocol SC #2714
approved as EXEMPT under CFR 46.101(b)(4) by the Wright State University IRB.
S. scabiei mite extract
An aqueous extract of Sarcoptes scabiei var. canis was prepared by homogenizing mites in
endotoxin-free water as previously described [14]. Following two 24-hr extractions, the super-
natants were collected by centrifugation, sterile-filtered (0.22 μm) into sterile vials and stored
at 4˚C. The protein content of this and all other samples was determined using the method of
Bradford with bovine serum albumin (BSA) as standard [15].
Identification of S. scabiei proteins and antigens
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Protein separation
Unless otherwise noted, the materials used for protein separation and analysis were obtained
from Bio-Rad Laboratories, Inc., Hercules, CA.
Proteins in the S. scabiei extract (40 mL containing 175 mg protein) were concentrated
using preparative isoelectric focusing (IEF) as previously described [16] using a Bio-Rad Roto-
for apparatus with ampholytes of pH 3–10 (BioLyte 3/10, 2% wt/vol final) and 5% glycerol.
Focusing at 5˚C for 5 hr at 12 W yielded 20 fractions with pH 1.6–13. Fractions 4–15 (pH 4–8
containing ~ 120 mg protein) were recombined and subjected to a second IEF separation.
Fraction 14 had the highest protein concentration (2.2 mg/mL) and a pH of 5.0 and was
selected for further study.
Two-dimensional (2D) gel electrophoresis was performed as previously described [14]. An
aliquot of Fraction 14 was prepared using the ReadyPrep 2-D Cleanup Kit and the resulting
protein sample was extracted into ReadyPrep Rehydration/Sample Buffer. Two identical sam-
ples, each containing ~200 μg of protein, were loaded onto 11 cm ReadyStrip pH 5–8 IPG
strips using overnight passive rehydration. Second dimension separation was carried out using
Criterion TGX Any kD precast gels as before. At the conclusion of the electrophoretic separa-
tion, one gel was stained with GelCode Blue Stain Reagent (Thermo Scientific, Rockford, IL).
The other gel was prepared for electrophoretic transfer.
Electrophoretic transfer and immunoblotting
Following 2D separation, the proteins on the second gel were transferred to an “Immun-Blot
PVDF Membrane for Protein Blotting” using condition as previously described [17]. PBST,
composed of Dulbecco’s Phosphate Buffered Saline + 1% Tween 20, was used as wash. BPBST
(PBST+ 1% BSA + 1% normal goat serum) was used to block the membranes and for antibody
dilutions except as noted.
A pool of serum from patients with confirmed ordinary scabies was prepared by combining
equal volumes of 5 individual serum samples [18]. The serum pool was diluted 1/60 and used
to probe the blot for 2 hrs. For IgM binding, the blot was probed for 1 hr in biotinylated-Goat
anti-Human IgM at 1/5000 and 1hr in streptavidin-Alkaline Phosphatase at 1/5000 (both from
Southern Biotechnology Associates, Birmingham, AL). Tris-buffered saline (TBS) replaced
PBS in wash and diluent prior to the Alkaline Phosphatase step. The blot was developed using
AP Blue Membrane Substrate (Sigma-Aldrich, St. Louis, MO) yielding blue spots where IgM
bound. The blot was imaged and subsequently re-probed for IgG binding using biotinylated-
Goat anti-Human IgG at 1/5000 and streptavidin-Horseradish Peroxidase at 1/5000 (Southern
Biotechnology Associates). IgG binding proteins were stained reddish-brown using the sub-
strate of Young [19]. Proteins that bound both IgM and IgG appeared purplish on the finished
blot.
Stained spot selection and protein identification
Both the stained gel and probed immunoblot were imaged and the images were overlaid with a
1,000-cell grid (25 row x 40 cells/row) as described before [14]. This allowed each stained pro-
tein spot on the gel and on the corresponding blot to be assigned a unique “spot number”
identifier.
Ninety-seven blue-stained spots were excised from the gel using a 1-mm spot picker, col-
lected into labeled LoBind tubes (Eppendorf, Westbury, NY) and frozen. Samples were
shipped to Applied Biomics (Hayward, CA) for trypsin digestion and sequencing by mass
spectrometry. Proteins were identified by MASCOT (Matrix Science, London, UK) search of
the National Center for Biotechnology Information non-redundant database (NCBInr) with
Identification of S. scabiei proteins and antigens
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taxonomy restricted to “Sarcoptes scabiei”. This database contains the complete genome and
predicted proteome for S. scabiei var. canis [20].
Recombinant protein expression and purification
Gene sequences for selected proteins were synthesized by GenScript (Piscataway, NJ) with
the open reading frame being codon-optimized for expression in E. coli. Additional modifica-
tions to the open reading frame were made to eliminate any internal BamHI, HindIII, and
KpnI restriction sites. The termini of each gene contained in-frame 5’ BamHI and 3’ HindIII
restriction sites for cloning into the pET-45b(+) expression vector. Expression vectors were
transformed into E. coli Rosetta(DE3) competent cells (EMD Millipore, Billerica, MA). Trans-
formants were selected on ampicillin-containing solid media plates, and 3-mL overnight liquid
cultures were generated from five separate single colonies. The overnight cultures were incu-
bated in liquid LB media that included ampicillin. All five cultures were then combined the
following morning and subcultured into 500 mL of LB media without ampicillin for 3 hrs, fol-
lowed by induction of protein expression by the addition of 1 mM (final concentration) IPTG
for three hours. All liquid cultures were maintained in a MaxQ 4000 orbital shaking incubator
(Thermo, Waltham, MA) shaking at 250 rpm and held at 32˚C. Cells were harvested by centri-
fugation at 5000 x g for 20 min. Cell pellets were stored at -80˚C until protein purification. Fro-
zen cell pellets were resuspended in 10 mL of ice cold 1x Tris Buffered Saline (25 mM Tris, 150
mM NaCl, pH 7.2) containing Pierce Protease Inhibitor without EDTA (Thermo, Waltham,
MA). Resuspended cells were disrupted by sonication on ice using 10 pulses of 30 sec on, 30
sec off with a 4710 series ultrasonic homogenizer (Cole Parmer, Vernon Hills, IL) set at 40%
amplitude. Cellular debris was pelleted by centrifugation, and the supernatant was filtered
through a 0.4 μm syringe filter. His-tagged proteins were then purified by column purification
on Pierce His Pur Cobalt chromatography columns (Thermo) according to the manufacturer’s
recommendations and using a final elution volume of 3 mL. Purified proteins were quantified
and analyzed as follows.
Immunoscreening of recombinant proteins
All recombinant proteins were subjected to an initial immunoblot screening. Aliquots of puri-
fied proteins (3–10 μg) were loaded onto the single prep-well of Mini-Protean TGX Any kD
Gels and electrophoresis was carried out at 200 V as recommended by the manufacturer
(BioRad) and as described previously [21, 22]. Separated proteins were then transferred to
PVDF membranes that were blocked as described above.
Ten pools of serum from patients with confirmed scabies infestations were prepared based
on prior assessment [13, 18]. A pool of serum from healthy control subjects was included as a
negative control. All proteins were tested with these sera. Eight proteins of interest were also
screened with serum from 30 individual patients with ordinary scabies and 10 uninfested con-
trols [13, 18].
Blots were loaded into a mini-slot blot apparatus (Mini-Protean Multiscreen, BioRad) [21,
22] and probed for 2 hrs with the sera as described above. After removal from the slot blot
apparatus, blots were sequentially developed for IgM and IgG binding as described above.
The purity of all individual proteins was also determined using electrophoresis on Mini-
Protean TGX Any kD Gels run as above and stained with GelCode Blue.
Results
Our previous analysis revealed that most of the soluble proteins present in an aqueous extract
of scabies mites had isoelectric points (pIs) in the range of pH 5–8 [14]. In the present analysis,
Identification of S. scabiei proteins and antigens
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we used preparative IEF to concentrate proteins with pIs in this vicinity and then used IPG
strips of pH 5–8 for final separation.
Ninety-seven protein-containing spots were excised from the GelCode Coomassie blue
stained gel and were submitted for sequence analysis (Fig 1). All 97 spots were identified as
containing one or more proteins of S. scabiei var. canis (Table 1). There were a total of 50 dif-
ferent S. scabiei proteins identified and 34 of these had not been previously reported (Fig 1,
Table 1). The proteins from an identical gel were transferred to a PVDF membrane that was
probed using a pool of sera from 5 patients with confirmed ordinary scabies infections that
had previously been determined to have high levels of circulating antibodies that recognized
antigens in S. scabiei extracts [13, 18]. Of the 97 protein-containing spots, one bound only
IgM, 32 bound only IgG and 29 bound both IgM and IgG (Fig 2, Table 1). No antibody bound
to 33 of the spots.
We previously postulated that a diagnostic test for scabies would require identifying a set of
antigens that selectively bind antibody (especially IgM) from the serum of patients suspected
of being infected with scabies mites [13]. Based on the antibody-binding profiles of the pro-
teins identified on the 2D gel and blot, we selected 14 proteins for further study as diagnostic
antigen candidates (Table 2). We also selected 9 additional proteins from the> 150 previ-
ously-identified proteins that could be among the molecules that are responsible for this mite’s
Fig 1. GelCode Coomassie blue stained 2-dimensional electrophoresis gel used to separate proteins of S. scabiei. Numbers in black denote those
identified proteins observed only on the stained gel. Numbers in red indicate identified proteins that also bound antibody (immunoblot shown in Fig 2) from
the serum of patients with ordinary scabies.
https://doi.org/10.1371/journal.pntd.0005669.g001
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Table 1. Identification of the S. scabiei proteins in the 97 spots excised from the GelCode Blue stained 2-D gel (Fig 1) and their antibody binding
profiles (Fig 2).
MW pI
Spot # New Accession # Protein Identification Pred Gel Pred Gel Ab Binding
135 KPM11560 Sar s 28 (heat shock protein 70-like protein 8) 62,302 86,015 5.49 6.08 None
136 KPM11560 Sar s 28 (heat shock protein 70-like protein 8) 62,302 85,976 5.49 6.15 None
165 ✔ KPM02263 Vitellogenin-like protein 220,647 70,206 6.03 5.38 IgM + IgG
166 ✔ KPM02263 Vitellogenin-like protein 220,647 69,195 6.03 5.47 IgM + IgG
167 ✔ KPM02263 Vitellogenin-like protein 220,647 70,799 6.03 5.53 IgM + IgG
174 KPM10172 Sar s 28 (heat shock protein 70-like protein 6) 77,075 71,005 6.50 6.01 IgG only
175 KPM10172 Sar s 28 (heat shock protein 70-like protein 6) 77,075 72,738 6.50 6.07 IgG only
176 KPM10172 Sar s 28 (heat shock protein 70-like protein 6) 77,075 74,713 6.50 6.15 IgG only
177 KPM11560 Sar s 28 (heat shock protein 70-like protein 8) 62,302 75,188 5.49 6.22 IgG only
179 KPM11560 Sar s 28 (heat shock protein 70-like protein 8) 62,302 74,328 5.49 6.35 None
180 ✔ KPM08931 Elongation factor G, mitochondrial-like protein 84,242 73,932 7.53 6.42 None
201 ✔ KPM02263 Vitellogenin-like protein 220,647 60,438 6.03 5.10 IgG only
202 ✔ KPM02263 Vitellogenin-like protein 220,647 60,675 6.03 5.19 IgG only
209 KPM06690 60 kDa Heat shock protein, mitochondrial-like protein 62,505 61,556 5.77 5.67 Neg stain
210 KPM06690 60 kDa Heat shock protein, mitochondrial-like protein 62,505 62,973 5.77 5.72 Neg stain
225 ✔ KPM07637 Actin-interacting protein 1-like protein 64,294 62,437 6.07 6.78 IgG only
226 ✔ KPM07637 Actin-interacting protein 1-like protein 64,294 62,437 6.07 6.78 IgG only
227 ✔ KPM07637 Actin-interacting protein 1-like protein 64,294 63,960 6.07 6.90 IgG only
248 ✔ KPM02263 Vitellogenin-like protein 220,647 53,200 6.03 5.60 None
249 ✔ KPM02263 Vitellogenin-like protein 220,647 52,287 6.03 5.68 None
251 ✔ KPM02263 Vitellogenin-like protein 220,647 51,639 6.03 5.81 None
256 KPM02829 Enolase-like protein 47,320 53,202 5.75 6.16 IgG only
257 KPM02829 Enolase-like protein 47,320 53,321 5.75 6.22 IgG only
262 ✔ KPM04850 Alpha-aminoadipic semialdehyde dehydrogenase-like protein 59,780 53,297 6.77 6.56 IgG only
263 ✔ KPL93612 Pyruvate kinase-like protein 56,757 54,597 6.03 6.63 IgG only
298 KPM02829 Enolase-like protein 47,320 47,163 5.75 6.30 IgM + IgG
303 ✔ KPM04598 Hypothetical protein QR98_0030480 53,449 48,048 6.13 6.65 IgM + IgG
306 ✔ KPM04598 Hypothetical protein QR98_0030480 53,449 48,011 6.13 6.84 IgM + IgG
328 ACC85688 Actin 41,570 42,022 5.22 5.61 IgM + IgG
329 KPM11937 Actin-like protein 6 16,941 42,138 4.66 5.68 IgM + IgG
335 ✔ KPM03560 Sar s 27 allergen (serpin-like protein 9) 46,965 40,933 5.68 6.08 IgG only
336 KPM02829 Enolase-like protein 47,320 40,307 5.75 6.17 IgG only
338 KPM02829 Enolase-like protein 47,320 40,313 5.75 6.30 IgG only
339 ✔ KPM09149 Fumarylacetoacetase-like protein 47,804 41,329 5.77 6.36 IgM + IgG
340 KPM02829 Enolase-like protein 47,320 40,148 5.75 6.43 IgG only
341 ✔ KPM09149 Fumarylacetoacetase-like protein 47,804 42,081 5.77 6.49 IgM + IgG
356 ✔ KPM04355 Isocitrate dehydrogenase [NADP] cytoplasmic-like protein 46,226 41,590 6.80 7.53 IgM + IgG
384* KPM02376 Sar s 20 allergen (arginine kinase like 1) 33,971 36,036 6.29 6.70 IgG only
384* ✔ KPM11752 Hypothetical protein QR98_0103270 39,594 8.07 IgG only
386* KPM02376 Sar s 20 allergen (arginine kinase like 1) 33,971 36,128 6.29 6.85 IgG only
386* ✔ KPM11752 Hypothetical protein QR98_0103270 39,594 8.07 IgG only
389* KPM02376 Sar s 20 allergen (arginine kinase like 1) 33,971 36,087 6.29 7.05 IgG only
389* ✔ KPM11752 Hypothetical protein QR98_0103270 39,594 8.07 IgG only
390* KPM02376 Sar s 20 allergen (arginine kinase like 1) 33,971 36,618 6.29 7.13 IgG only
390* ✔ KPM11752 Hypothetical protein QR98_0103270 39,594 8.07 IgG only
(Continued )
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Table 1. (Continued)
MW pI
Spot # New Accession # Protein Identification Pred Gel Pred Gel Ab Binding
392 KPM02376 Sar s 20 allergen (arginine kinase like 1) 33,971 36,162 6.29 7.25 IgG only
397 ✔ KPM11752 Hypothetical protein QR98_0103270 39,594 36,692 8.07 7.62 IgG only
401 AFH08744 Tropomyosin 32,907 32,450 4.75 5.12 None
407 KPM02829 Enolase-like protein 47,320 33,449 5.75 5.54 None
410 ✔ KPM05552 Sar s 32 allergen (inorganic pyrophosphatase-like protein) 34,225 33,805 5.40 5.75 IgG only
412 ✔ KPM02263 Vitellogenin-like protein 220,647 33,131 6.03 5.88 None
416 ✔ KPM08991 Hypothetical protein QR98_0075200 9,170 32,823 6.73 6.17 None
418 ✔ KPM08991 Hypothetical protein QR98_0075200 9,170 32,135 6.73 6.29 None
419 ✔ KPM06764 Mediator of RNA polymerase II transcription subunit 8-like protein 26,845 32,255 7.79 6.37 None
425 ✔ KPM03187 Ester hydrolase C11orf54-like protein 36,806 32,243 6.11 6.77 IgM + IgG
430 ✔ KPM05576 Glyceraldehyde-3-phosphate dehydrogenase 2-like protein 36,680 33,062 6.67 7.12 IgM + IgG
432 KPM02376 Sar s 20 allergen (arginine kinase like 1) 33,971 33,121 6.29 7.25 IgG only
434 ✔ KPM05576 Glyceraldehyde-3-phosphate dehydrogenase 2-like protein 36,680 33,121 6.67 7.38 IgM + IgG
435 ✔ KPM02263 Vitellogenin-like protein 220,647 32,425 6.03 7.46 None
442 AFH08744 Tropomyosin 32,907 29,803 4.75 5.20 None
458 ✔ KPM10460 Glyoxalase domain-containing protein 4-like protein 30,916 29,727 5.23 6.29 IgG only
460 ✔ KPM10460 Glyoxalase domain-containing protein 4-like protein 30,916 29,561 5.23 6.43 IgG only
468 KPM04864 Malate dehydrogenase, cytoplasmic-like protein 34,948 28,983 6.07 6.97 IgM + IgG
471 KPM04864 Malate dehydrogenase, cytoplasmic-like protein 34,948 29,124 6.07 7.19 IgM + IgG
528 ✔ KPM11752 Hypothetical protein QR98_0103270 39,594 23,785 8.07 5.59 None
529 KPM11560 Sar s 28 (heat shock protein 70-like protein 8) 62,302 24,258 5.49 5.68 IgG only
538 ✔ KPM02928 Citrate synthase 1, mitochondrial-like protein 51,707 24,123 7.75 6.30 None
541 ✔ KPM04580 Sar s 16 allergen (gelsolin-like protein) 54,930 23,992 6.08 6.50 None
569 KPM11560 Sar s 28 (heat shock protein 70-like protein 8) 62,302 22,281 5.49 5.68 IgG only
572 KPM11560 Sar s 28 (heat shock protein 70-like protein 8) 62,302 22,111 5.49 5.88 IgG only
576* ✔ KPM11822 Dehydrogenase/reductase SDR family member 2-like protein 58,241 22,320 8.09 6.16 IgM + IgG
576* ✔ KPM03144 Haloacid dehalogenase-like hydrolase domain-containing protein 31,713 5.63 IgM + IgG
577 ✔ KPM02528 Proteasome subunit beta type-4-like protein 27,132 22,360 5.79 6.21 IgM + IgG
580 ✔ KPM11822 Dehydrogenase/reductase SDR family member 2-like protein 58,241 22,082 8.09 6.44 IgM + IgG
581 ✔ KPM11822 Dehydrogenase/reductase SDR family member 2-like protein 58,241 21,974 8.09 6.49 IgM + IgG
585 ✔ KPM11822 Dehydrogenase/reductase SDR family member 2-like protein 58,241 22,073 8.09 6.79 IgM + IgG
620 ✔ KPM02662 Proteasome subunit alpha type-2-like protein 47,963 20,507 10.13 6.43 IgG only
621 ACX33880 Glutathione S-transferase delta class 3, partial 21,192 20,680 6.13 6.49 None
626* ✔ KPM09477 Proteasome subunit alpha type-6-like protein 26,986 20,751 6.24 6.85 IgM + IgG
626* ✔ KPM10536 Short-chain alcohol dehydrogenase-like protein 26,299 5.57 IgM + IgG
628 KPM10468 Sar s 25 allergen (triosephosphate isomerase-like protein) 26,678 20,128 6.13 6.99 IgM + IgG
649 ✔ KPM04725 Sar s 30 allergen (ferritin-like protein 3) 21,807 19,090 5.19 5.66 None
651 ✔ KPM04725 Sar s 30 allergen (ferritin-like protein 3) 21,807 18,916 5.19 5.80 IgG only
656 ✔ KPM04725 Sar s 30 allergen (ferritin-like protein 3) 21,807 19,261 5.19 6.15 None
658 ✔ KPM03215 Phosphatidylethanolamine-binding protein-like protein F40A3.3-like protein 20,465 18,433 5.87 6.30 IgM + IgG
671 ✔ KPM03215 Phosphatidylethanolamine-binding protein-like protein F40A3.3-like protein 20,465 18,655 5.87 7.17 IgM + IgG
702 ✔ KPM03215 Phosphatidylethanolamine-binding protein-like protein F40A3.3-like protein 20,465 17,609 5.87 6.58 None
773 ✔ KPM03156 14-3-3 protein-like protein 1 28,027 15,193 4.79 5.95 IgM only
774 ✔ KPM06865 Disulfide-isomerase A3-like protein 59,046 15,064 5.78 6.02 None
776* KPL97138 Stress-induced-phosphoprotein 1-like protein 37,044 7.53 None
776* ✔ KPM02263 Vitellogenin-like protein 220,647 15,071 6.03 6.16 None
(Continued )
Identification of S. scabiei proteins and antigens
PLOS Neglected Tropical Diseases | https://doi.org/10.1371/journal.pntd.0005669 June 12, 2017 7 / 12
ability to modulate its host’s immune responses (Table 2) [12, 14]. The genes coding for these
23 proteins were deduced from the S. scabiei var. canis genome [20], chemically synthesized,
and cloned into E. coli. The recombinant proteins were expressed and partially purified before
being subjected to immunoblot screening. GelCode Coomassie blue stained gels showed that
the purity of the recombinant proteins ranged from 10% to 95%.
For the first round of immunoscreening, ten pools of serum from patients with confirmed
scabies infections were prepared based on prior screening [13, 18]. Another pool of sera from
uninfected subjects was also prepared to serve as a negative control. Each of the 23 proteins
was then screened with these 11 serum pools by slot blot. Eight of the 14 proteins that were
selected as diagnostic antigen candidates were recognized by antibodies in 50% of the test
serum pools (Table 2). None of the candidate immunomodulatory proteins bound antibodies
in more than 20% of the test sera.
The 8 most promising diagnostic antigen candidates were subjected to a second round of
screening using the serum of 30 individual US patients with ordinary scabies and 10 unin-
fected controls [13, 18]. One protein (KPM11752), a hypothetical protein that appears unique
to scabies mites, was recognized by antibodies present in the serum of all scabies patients and
all control subjects (Table 3). Three other proteins (KPM03215, KPM07763 and KPM10468)
bound antibodies present in the serum of 40–67% of the scabies patients but they were also
recognized by 10–40% of the control sera. Two of these are homologs of the Group 13 and 25
dust mite allergens. The remaining candidate proteins were recognized by 30% of the serum
from the scabies patients.
Discussion
This research builds on previous proteomic work by identifying 50 different proteins produced
by S. scabiei, 34 of which were not identified previously [14]. We determined that 66% of the
Table 1. (Continued)
MW pI
Spot # New Accession # Protein Identification Pred Gel Pred Gel Ab Binding
785 ✔ KPM11739 Superoxide dismutase [Cu-Zn]-like protein 16,109 14,874 6.02 6.76 None
812 ✔ KPM08623 Sar s 31 allergen (cofilin-like protein) 16,821 13,931 5.95 5.88 IgM + IgG
816 ✔ KPM02263 Vitellogenin-like protein 220,647 13,965 6.03 6.16 None
817 ✔ KPM08623 Sar s 31 allergen (cofilin-like protein) 16,821 13,923 5.95 6.22 IgM + IgG
820 ✔ KPM02263 Vitellogenin-like protein 220,647 14,107 6.03 6.45 None
831 KPM06968 Nucleoside diphosphate kinase B-like protein 14,100 14,241 9.88 7.21 IgM + IgG
897 ✔ KPM07763 Sar s 13 allergen (lipocalin-like protein) 14,867 12,328 6.37 6.24 IgM + IgG
901 ✔ KPM07609 CUB domain containing protein 4 122,775 12,301 5.67 6.50 None
928 KPM09467 Thioredoxin-like protein 2 11,704 11,508 5.06 5.60 None
930 ✔ KPM04598 Hypothetical protein QR98_0030480 53,449 11,587 6.13 5.73 None
934 ✔ KPL94049 Muscular protein 20-like protein 15,837 11,581 6.73 6.02 None
936* ✔ KPM03769 Hypothetical protein QR98_0022030 18,008 11,514 4.81 6.15 None
936* ✔ KPL94049 Muscular protein 20-like protein 15,837 6.73 None
941 ✔ KPL94049 Muscular protein 20-like protein 15,837 11,560 6.73 6.51 None
Proteins are denoted by spot numbers that correspond to those shown in Figs 1 and 2.
* indicates that the spot contained a mixture of proteins. ✔ denotes proteins that were not previously identified [14]. Molecular weights (MW) and isoelectric
points (pI) predicted for each protein and determined from the gel are given. Immunoblot binding of IgM only, IgG only or both IgM and IgG is indicated.
Some proteins did not bind antibody (None) and two proteins appeared negatively stained (white spots) on the immunoblot.
https://doi.org/10.1371/journal.pntd.0005669.t001
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protein-containing spots were recognized by IgM and/or IgG that is circulating in the serum
of patients with ordinary scabies at the time of initial diagnosis and selected 14 of these for
screening as candidates for use in a diagnostic test for scabies. Additionally, we identified 33
protein-containing spots, representing 16 different proteins, that were isolated from a Coo-
massie blue stained gel that did not bind patient antibody. Included among this set of proteins
may be molecules that participate in the parasite’s immune evasion mechanisms and are
responsible for modulating the host’s immune responses [1–12].
Unfortunately none of the 14 proteins selected as potential diagnostic antigens shows
enough promise to warrant further study. Only two proteins (KPM07763 and KPM11752) had
sensitivities of 67% but neither offered a specificity of> 40% (Table 3). An additional 19 dif-
ferent antibody-binding proteins were identified on the 2D immunoblot and these are also
potential candidates for use as diagnostic antigens (Table 1, Fig 2). It is possible that screening
of these proteins could yield candidates promising better sensitivity and specificity than those
reported here.
Perhaps more interesting are the data for the 9 proteins selected for the possibility that they
may be immunomodulatory. All were identified in a previous study [14] or were predicted
from the genome [20] and none were detected on the 2D immunoblot (Fig 2). Among these
were calmodulin-, calreticulin- and cystatin-like proteins, all of which have been shown to be
produced by other parasites and to possess immunomodulatory properties [23, 24]. For a
Fig 2. Immunoblot of 2-dimensional electrophoresis gel used to separate proteins of S. scabiei. Numbers in red indicate identified proteins that
bound antibody from the serum of patients with ordinary scabies.
https://doi.org/10.1371/journal.pntd.0005669.g002
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Table 2. First round screening of recombinant S. scabiei proteins for their ability to bind IgM and/or IgG from the serum of patients with ordinary
scabies.
Accession # Protein Identification IgM IgG IgM -/+ IgG
Diagnostic antigen candidates
KPM03156 14-3-3 protein-like protein 1 7/10 10/10 10/10
KPM09740 2,3-bisphosphoglycerate-independent phosphoglycerate mutase-like protein - - -
KPM11822 Dehydrogenase/reductase SDR family member 2-like protein - 1/10 1/10
KPM02829 Enolase-like protein 10/10 10/10 10/10
KPM03144 Haloacid dehalogenase-like hydrolase domain-containing protein - 2/10 2/10
KPM04864 Malate dehydrogenase, cytoplasmic-like protein - - -
KPM03215 Phosphatidylethanolamine-binding protein-like protein F40A3.3-like protein 4/10 5/10 5/10
KPM09477 Proteasome subunit alpha type-6-like protein - - -
KPM07763 Sar s 13 allergen (lipocalin-like protein) 3/10 10/10 10/10
KPM10468 Sar s 25 allergen (triosephosphate isomerase-like protein) 10/10 10/10 10/10
KPM08623 Sar s 31 allergen (cofilin-like protein) 5/10 10/10 10/10
KPM10536 Short-chain alcohol dehydrogenase-like protein - - -
KPM11752 Hypothetical protein QR98_0103270 10/10 10/10 10/10
KPM04725 Sar s 30 allergen (ferritin-like protein 3) 3/10 10/10 10/10
Immunomodulatory molecule candidates
KPM11739 Superoxide dismutase [Cu-Zn]-like protein - - -
KPM07532 Calmodulin-like - 2/10 2/10
KPM04170 Calreticulin-like 1/10 - 1/10
KPM09372 Cystatin-C-like protein - - -
KPM09373 Cystatin-like protein - - -
KPM09123 Hypothetical protein QR98_0076540 - - -
KPM07951 Mannan-binding lectin serine protease 1-like - - -
KPM05304 Matrix metalloproteinase-like - - -
KPM02741 Membrane metallo-endopeptidase-like 1-like 1/10 2/10 2/10
Each protein was tested with 10 pools of serum from patients with ordinary scabies. The number of pools out of 10 that had specific antibody isotypes
directed at each protein is shown.
https://doi.org/10.1371/journal.pntd.0005669.t002
Table 3. Second round screening of recombinant S. scabiei proteins for their ability to bind IgM and/or IgG from the serum of patients with ordi-
nary scabies and from uninfected control subjects.
Patients Controls
Accession # Protein Identification IgM IgG IgM -/+ IgG IgM -/+ IgG
KPM03156 14-3-3 protein-like protein 1 4/30 7/30 7/30 2/10
KPM02829 Enolase-like protein 0/30 3/30 3/30 0/10
KPM03215 Phosphatidylethanolamine-binding protein-like protein F40A3.3-like protein 12/30 12/30 12/30 1/10
KPM07763 Sar s 13 allergen (lipocalin-like protein) 11/30 15/30 20/30 4/10
KPM10468 Sar s 25 allergen (triosephosphate isomerase-like protein) 6/30 7/30 13/30 3/10
KPM08623 Sar s 31 allergen (cofilin-like protein) 9/30 9/30 9/30 3/10
KPM11752 Hypothetical protein QR98_0103270 30/30 30/30 30/30 10/10
KPM04725 Sar s 30 allergen (ferritin-like protein 3) 3/30 3/30 5/30 0/10
Each protein was tested with serum from 30 individual patients with ordinary scabies and from 10 uninfected control subjects. The number of individual sera
out of 30 that had specific antibody isotypes directed at each protein is shown.
https://doi.org/10.1371/journal.pntd.0005669.t003
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protein to be effective in assisting the mite to evade the host’s immune response it would likely
also be able to escape detection by the adaptive immune system and would not elicit an anti-
body response. As would be expected, 3 of the 9 proteins tested were recognized by antibodies
in the serum of 20% of the scabietic patients while the other 6 did not bind any antibody. A
logical next step would be to test these proteins for their immunomodulatory properties,
although this was beyond the scope of the present study.
Conclusions
Thirty-three proteins that bound IgM and/or IgG from the serum of patients with ordinary
scabies were identified. Although none of the 14 tested are useful for inclusion in a diagnostic
test, the identity of 19 other candidates is provided. The identity of 16 proteins that are not rec-
ognized as antigens by infected patients was also determined. These could be among the mole-
cules that are responsible for this mite’s ability to modulate its host’s innate and adaptive
immune responses.
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